Silicon Valley-based Cognoa, founded in 2014, offers a tool to evaluate childhood development and highlight development delays and autism. The development evaluation, supported by AI and created in partnership with Harvard and Stanford Medical Schools, covers children aged 1-8. Clinical studies show that the diagnostic tool is significantly more accurate than standard practice screeners of the same age. The company also provides clinical advice, improves childhood development and, when necessary, recommends clinical and medical support. Parent testimonials highlight the range of available activities to help needy children and parents facing similar problems.